Global trastuzumab biosimilar market is expected to grow at rapid pace with strong presence of major players such as Amgen Inc., Biocon Limited, Mylan Inc., BioXpress Therapeutics SA, Celltrion, Teva Pharmaceutical Industries Ltd., Apotex Inc., Pfizer Inc

InsightAce Analytic Pvt. Ltd. announces the release of market assessment report on 'Global Trastuzumab Biosimilar Market Assessment – Revenue Forecast, Clinical Trial/Pipeline Analysis, Brand/Originator Drug Historic Revenue and Forecast Till 2026'

Request for ToC/Proposal: https://bit.ly/2sZnQAW

Trastuzumab is marketed under the trade/brand name of Herceptin. It is developed by F. Hoffmann-La Roche AG and was approved by U.S Food Drug Administration (FDA) in 1998 and by European Medicines Agency in 2000. Trastuzumab is a recombinant DNA-derived humanized monoclonal antibody that binds to human epidermal growth factor receptor 2 (HER2). It is also approved for the treatment of HER2 positive breast cancer as well as it is also approved for the treatment of metastatic breast cancer and gastric cancer. Patent of Herceptin expired in Europe in 2014, in Asia in 2017, and in the U.S. the patent will expire in 2019.
Samsung Bioepis announced the launch of first biosimilar for trastuzumab i.e Ontruzant in Europe on November 2017, thus entry of biosimilar into the market have boosted the growth of trastuzumab biosimilar market.

The trastuzumab biosimilar market is fragmented/consolidated with presence of many/few players that operates in local as well as international market.
Global trastuzumab biosimilar Market reports cover prominent players like Amgen Inc., Biocon Limited, Mylan Inc., BioXpress Therapeutics SA, Celltrion, Teva Pharmaceutical Industries Ltd., Apotex Inc., Pfizer Inc., AryoGen Pharmed, Samsung BioepisCo., Ltd., and Merck & Co.

Curious about this latest version of report?

Obtain Report Details @ https://bit.ly/2sZnQAW

Market Segments

• Global Trastuzumab Biosimilar Market Outlook (Revenue, US$ Mn, 2017 - 2027) By Application
o Breast Cancer
o Gastric Cancer
o Other

• Global Trastuzumab Biosimilar Market Outlook (Revenue, US$ Mn, 2017 - 2027) By Distribution Channel
o Hospital Pharmacy
o Online Pharmacy
o Retail Pharmacy
o Other Direct Distribution Channels

Why should buy this report:
 To receive a comprehensive analysis of the prospects for global trastuzumab biosimilar market
 To receive industry overview and future trends trastuzumab biosimilar market
 To analyze the trastuzumab biosimilar market drivers and challenges
 To get information on trastuzumab biosimilar market size and forecast
 To get details on trastuzumab biosimilar clinical trial/pipeline analysis
 Originator drug historic revenue
 Originator drug key news/industry activities
 Major Mergers & Acquisition in trastuzumab biosimilar industry

InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Email us: info@insightaceanalytic.com
Call us: +1 718 593 4405
Pune, Maharashtra 411004

This release was published on openPR.